| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72888-047-01 | 72888-047 | HUMAN PRESCRIPTION DRUG | Acetazolamide | Acetazolamide | TABLET | ORAL | 20210819 | N/A | ANDA | ANDA215101 | Advagen Pharma Ltd | ACETAZOLAMIDE | 125 mg/1 | 100 TABLET in 1 BOTTLE (72888-047-01) |
| 72888-048-01 | 72888-048 | HUMAN PRESCRIPTION DRUG | Acetazolamide | Acetazolamide | TABLET | ORAL | 20210819 | N/A | ANDA | ANDA215101 | Advagen Pharma Ltd | ACETAZOLAMIDE | 250 mg/1 | 100 TABLET in 1 BOTTLE (72888-048-01) |
| 68071-3550-1 | 68071-3550 | HUMAN PRESCRIPTION DRUG | Acetazolamide | Acetazolamide | TABLET | ORAL | 20231201 | N/A | ANDA | ANDA215101 | NuCare Pharmaceuticals,Inc. | ACETAZOLAMIDE | 125 mg/1 | 12 TABLET in 1 BOTTLE (68071-3550-1) |
| 71335-2215-1 | 71335-2215 | HUMAN PRESCRIPTION DRUG | Acetazolamide | Acetazolamide | TABLET | ORAL | 20230815 | N/A | ANDA | ANDA215101 | Bryant Ranch Prepack | ACETAZOLAMIDE | 250 mg/1 | 100 TABLET in 1 BOTTLE (71335-2215-1) |